Targeting Angiogenesis in Childhood Sarcomas

Por Bid, Hemant K., Houghton, Peter J.
Publicado em 2011

Vitamin D receptor and type 2 diabetes mellitus: Growing therapeutic opportunities

Por Manchanda, Parmeet Kaur, Bid, Hemant K.
Publicado em 2012

Predisposition of genetic polymorphism with the risk of urolithiasis

Por Mittal, Rama D., Bid, Hemant K., Manchanda, Parmeet K., Kapoor, Rakesh
Publicado em 2008

Potent Inhibition of Angiogenesis by the IGF-1 Receptor-Targeting Antibody SCH717454 is Reversed by IGF-2

Por Bid, Hemant K., Zhan, Jun, Phelps, Doris, Kurmasheva, Raushan T., Houghton, Peter J.
Publicado em 2011

Anti-Tumor Activity of a Novel HS-Mimetic-Vascular Endothelial Growth Factor Binding Small Molecule

Por Sugahara, Kazuyuki, Thimmaiah, Kuntebommanahalli N., Bid, Hemant K., Houghton, Peter J., Rangappa, Kanchugarakoppal S.
Publicado em 2012

Correction: Anti-Tumor Activity of a Novel HS-Mimetic-Vascular Endothelial Growth Factor Binding Small Molecule

Por Sugahara, Kazuyuki, Thimmaiah, Kuntebommanahalli N., Bid, Hemant K., Houghton, Peter J., Rangappa, Kanchugarakoppal S.
Publicado em 2012

Vitamin D receptor as a therapeutic target for benign prostatic hyperplasia

Por Manchanda, Parmeet Kaur, Kibler, Aaron J, Zhang, Mei, Ravi, Janani, Bid, Hemant K.
Publicado em 2012

Anti-Angiogenic Activity of a Small Molecule STAT3 Inhibitor LLL12

Por Bid, Hemant K., Oswald, Duane, Li, Chenglong, London, Cheryl A., Lin, Jiayuh, Houghton, Peter J.
Publicado em 2012

p53/TAp63 and AKT Regulate Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling through Two Independent Parallel Pathways in the Presence of DNA Damage

Por Cam, Maren, Bid, Hemant K., Xiao, Linlin, Zambetti, Gerard P., Houghton, Peter J., Cam, Hakan
Publicado em 2014

ΔNp63 promotes pediatric neuroblastoma and osteosarcoma by regulating tumor angiogenesis

Por Bid, Hemant K., Roberts, Ryan D., Cam, Maren, Audino, Anthony, Kurmasheva, Raushan T., Lin, Jiayuh, Houghton, Peter J., Cam, Hakan
Publicado em 2013

Dual Targeting of the Type 1 Insulin-like Growth Factor Receptor and its Ligands as an Effective Anti-angiogenic Strategy

Por Bid, Hemant K., London, Cheryl A., Gao, Jin, Zhong, Haihong, Hollingsworth, Robert E., Fernandez, Soledad, Mo, Xiaokui, Houghton, Peter J.
Publicado em 2013

The Bromodomain BET inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma

Por Bid, Hemant K., Phelps, Doris A., Xaio, Linlin, Guttridge, Denis C., Lin, Jiayuh, London, Cheryl, Baker, Laurence H., Mo, Xiaokui, Houghton, Peter J.
Publicado no Mol Cancer Ther (2016)

Detection and Biological Activities of Carboxyethylpyrrole Ethanolamine Phospholipids (CEP-EPs)

Por Wang, Hua, Guo, Junhong, West, Xiaoxia Z., Bid, Hemant K., Lu, Liang, Hong, Li, Jang, Geeng-Fu, Zhang, Lei, Crabb, John W., Linetsky, Mikhail, Salomon, Robert G.
Publicado no Chem Res Toxicol (2014)

Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor

Por McCann, Georgia A., Naidu, Shan, Rath, Kellie S., Bid, Hemant K., Tierney, Brent J., Suarez, Adrian, Varadharaj, Saradhadevi, Zhang, Jianying, Hideg, Kálmán, Houghton, Peter, Kuppusamy, Periannan, Cohn, David E., Selvendiran, Karuppaiyah
Publicado no Oncoscience (2014)

Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma

Por Bid, Hemant K., Kibler, Aaron, Phelps, Doris A., Manap, Sagymbek, Xiao, Linlin, Lin, Jiayuh, Capper, David, Oswald, Duane, Geier, Brian, DeWire, Mariko, Smith, Paul D., Kurmasheva, Raushan T., Mo, Xiaokui, Fernandez, Soledad, Houghton, Peter J.
Publicado em 2013

HO-3867, a Safe STAT3 Inhibitor, Is Selectively Cytotoxic to Ovarian Cancer

Por Rath, Kellie S., Naidu, Shan K., Lata, Pushpa, Bid, Hemant K., Rivera, Brian K., McCann, Georgia A., Tierney, Brent J., ElNaggar, Adam C., Bravo, Veronica, Leone, Gustavo, Houghton, Peter, Hideg, Kálmán, Kuppusamy, Periannan, Cohn, David E., Selvendiran, Karuppaiyah
Publicado no Cancer Res (2014)